The Frontier Within (Part 3): Green Signals from the FDA for Human Digitization

This is the third in our blog series on “digitizing the human body.” (Also see Part 1 and Part 2.) Human digitization has moved closer to reality, with three recent FDA-related developments strongly suggesting that regulatory hurdles to cutting-edge life sciences technologies are less daunting than generally assumed:  #1: Approval of a Digital Pill The […]

Read More